Health&Beauty- Page 107

The FINANCIAL -- Novartis Consumer Health  informed customers, that it is voluntarily recalling all lots of select bottle packaging configurations from retailers of Excedrin and NoDoz products with expiry dates of December 20, 2014 or earlier as well as Bufferin and Gas-X

The FINANCIAL -- EFPIA, the voice of the research-based pharmaceutical industry in Europe, supports the idea to establish a “European Council for Health Research”, launched last week by the Alliance for Biomedical Research in Europe representing 16 leading European biomedical research societies,

The FINANCIAL -- One year after the opening of its U.S. Innovation Center, Bayer HealthCare is expanding its U.S. research model, according to Bayer HealthCare.

The FINANCIAL -- Bayer HealthCare and Regeneron Pharmaceuticals, Inc. today announced that in an integrated analysis of two parallel Phase III studies in patients with the neovascular form of age-related macular degeneration, patients treated with VEGF Trap-Eye showed a sustained improvement in

The FINANCIAL -- On the occasion of the World Diabetes Congress in Dubai, the International Diabetes Federation has started the “Young Leaders in Diabetes Programme”.

The FINANCIAL -- People who live in areas with high levels of traffic-related air pollution may face a slightly increased risk of developing diabetes, Danish researchers conclude in a new study.

The FINANCIAL -- The American Optometric Association is using National Diabetes Awareness Month to urge Americans living with diabetes to schedule yearly comprehensive eye exams to help detect diabetic eye disease.

The FINANCIAL -- Novartis announced that Rasitrio, the first triple combination of aliskiren, amlodipine and hydrochlorothiazide in a single pill,1 has received approval from the European Commission for the treatment of high blood pressure.

The FINANCIAL -- Bayer HealthCare and Regeneron Pharmaceuticals, Inc. today announced that they have initiated a Phase III clinical trial evaluating the efficacy and safety of VEGF Trap-Eye in the neovascular form of age-related macular degeneration in China.

The FINANCIAL -- Living in the twenty first century means that it is now possible for people to treat the embarrassing problem hirsutism, when excessive hairiness occurs on women’s bodies in those places where terminal hair does not normally occur, specialists say.